Michael Curl, OD | |
191 Old Courthouse Rd, Appomattox, VA 24522-9853 | |
(434) 385-5400 | |
(434) 455-7172 |
Full Name | Michael Curl |
---|---|
Gender | Male |
Speciality | Optometry |
Experience | 18 Years |
Location | 191 Old Courthouse Rd, Appomattox, Virginia |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1750498135 | NPI | - | NPPES |
0618001585 | Other | VA | STATE LICIENSE |
P00399158 | Other | VA | MEDICARE RAILROAD |
P00458189 | Other | VA | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 0618001585 (Virginia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
David M Harman Md Llc | 6305828062 | 45 |
News Archive
RTP Company, a leading global compounder of custom engineered thermoplastics, is exhibiting at MD&M East from June 12-14, 2018 at the Jacob Javits Convention Center in New York city. Located in Booth #844, RTP Company will highlight several plastic technologies designed specifically to improve the longevity and functionality of medical equipment and devices.
The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.
Circadian Technologies has announced today that in conjunction with Cincinnati Children's Hospital Medical Center it has begun offering its LAM diagnostic, which is offered as a laboratory test compliant with CAP (College of American Pathologists) /CLIA regulations.
A recently discovered prostate cancer-selective antigen has been identified as a useful molecular imaging target for the detection and targeting of metastatic prostate cancer lesions, as reported in the November issue of The Journal of Nuclear Medicine.
Human pluripotent stem cells can infinitely self-renew and develop into all major cell types in the body, making them important for organ repair and replacement. But culturing them in large quantities can be expensive. Now, scientists at Japan's Kyoto University, with colleagues in India and Iran, have developed a more cost-effective culture by using a new combination of chemical compounds.
› Verified 9 days ago
Provider Name | David M Harman Md Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1306950431 PECOS PAC ID: 6305828062 Enrollment ID: O20040605000053 |
News Archive
RTP Company, a leading global compounder of custom engineered thermoplastics, is exhibiting at MD&M East from June 12-14, 2018 at the Jacob Javits Convention Center in New York city. Located in Booth #844, RTP Company will highlight several plastic technologies designed specifically to improve the longevity and functionality of medical equipment and devices.
The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.
Circadian Technologies has announced today that in conjunction with Cincinnati Children's Hospital Medical Center it has begun offering its LAM diagnostic, which is offered as a laboratory test compliant with CAP (College of American Pathologists) /CLIA regulations.
A recently discovered prostate cancer-selective antigen has been identified as a useful molecular imaging target for the detection and targeting of metastatic prostate cancer lesions, as reported in the November issue of The Journal of Nuclear Medicine.
Human pluripotent stem cells can infinitely self-renew and develop into all major cell types in the body, making them important for organ repair and replacement. But culturing them in large quantities can be expensive. Now, scientists at Japan's Kyoto University, with colleagues in India and Iran, have developed a more cost-effective culture by using a new combination of chemical compounds.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Curl, OD Po Box 1290, Forest, VA 24551-1290 Ph: (434) 385-5400 | Michael Curl, OD 191 Old Courthouse Rd, Appomattox, VA 24522-9853 Ph: (434) 385-5400 |
News Archive
RTP Company, a leading global compounder of custom engineered thermoplastics, is exhibiting at MD&M East from June 12-14, 2018 at the Jacob Javits Convention Center in New York city. Located in Booth #844, RTP Company will highlight several plastic technologies designed specifically to improve the longevity and functionality of medical equipment and devices.
The U.S. Food and Drug Administration today approved Stendra (avanafil), a new drug to treat erectile dysfunction.
Circadian Technologies has announced today that in conjunction with Cincinnati Children's Hospital Medical Center it has begun offering its LAM diagnostic, which is offered as a laboratory test compliant with CAP (College of American Pathologists) /CLIA regulations.
A recently discovered prostate cancer-selective antigen has been identified as a useful molecular imaging target for the detection and targeting of metastatic prostate cancer lesions, as reported in the November issue of The Journal of Nuclear Medicine.
Human pluripotent stem cells can infinitely self-renew and develop into all major cell types in the body, making them important for organ repair and replacement. But culturing them in large quantities can be expensive. Now, scientists at Japan's Kyoto University, with colleagues in India and Iran, have developed a more cost-effective culture by using a new combination of chemical compounds.
› Verified 9 days ago
Harman Eye Center Of Appomattox And Associates Plc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 191 Old Courthouse Road, Appomattox, VA 24522 Phone: 434-352-0700 Fax: 434-385-1414 | |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 7803 Richmond Hwy, Appomattox, VA 24522 Phone: 434-352-5908 Fax: 434-352-2918 |